Why the study?
Does the second-generation C200/C22 ELISA improve early detection of HCV antibodies compared to the first-generation C100 ELISA in transfusion recipients?
Does the second-generation C200/C22 ELISA improve early detection of HCV antibodies compared to the first-generation C100 ELISA in transfusion recipients?
The second-generation C200/C22 ELISA is more sensitive and detects HCV antibodies earlier than the first-generation C100 ELISA in early HCV infection.
No takes yet. Share an insight, caveat, or question.
C200/C22 ELISA may enable earlier post-transfusion HCV detection; leaves open clinical adoption pending larger prospective studies.
Poel et al. (1992) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: